DLRG welcomes two new PhD students from Chemical and Biomolecular Engineering who will lead projects in synthetic glycobiology and immunoengineering
Belen Sotomayor (pictured at left) recently joined the DeLisa group and will be working on experimental and computational optimization of glycosylation for making protein therapeutics and vaccines. Belen is a graduate student in the field of Chemical and Biomolecular Engineering (CBE). Prior to coming to Cornell, Belen earned her BS degree in Chemical Engineering at the Universidad Técnica Particular de Loja (UTPL) in Loja, Ecaudor.
Erik Bidstrup (pictured at left) also recently joined the DeLisa group. Erik is a first-year PhD student in CBE at Cornell. He will be working on the design and engineering of a novel cell-free platform for low-cost, scalable production of therapeutic antibodies with the goal of democratizing access to these life-saving medicines. To tackle this problem, he will make use of state-of-the-art methods in cell-free protein synthesis, synthetic glycobiology, and immunoengineering. Erik completed his BS in Chemical and Biological Engineering at Northwestern University.